Genome wide association studies have uncovered the importance of multiple gene variants in psychiatric disorders. Genotypes and biomarkers in combination with clinical features will help to address heterogeneity in patient phenotypes. New biomarkers will help to identify the onset of pathology long before clinical symptoms emerge, thus allowing early intervention and prediction of outcome.
FROM GENES TO THERAPIES
Hundreds of millions of people around the world are affected by mental disorders. These conditions have been poorly understood for centuries; however, modern psychiatry is now starting to explore the genetic, cellular and neural-network perturbations that underpin mental illness, with the aim of identifying biological indicators — or biomarkers — that can be used for diagnosis, prognosis and therapeutic intervention.
Source and/or read more: http://goo.gl/j7xiH
Publisher and/or Author and/or Editor:__Andres Agostini ─ @Futuretronium at Twitter! Futuretronium Book at http://3.ly/rECc